Compound ID | 1848
Class: Aminoglycoside
Spectrum of activity: | Gram-negative |
Details of activity: | Inhibits protein synthesis by binding to the 30S subunit of the bacterial ribosome. Active against Gram-negative bacteria |
Description: | Semisynthetic, derived from sisomicin. Primarily used for topical application |
Year first mentioned: | 1973 |
Highest developmental phase: | Approved by FDA in 1983 |
Development status: | Discontinued |
Reason Dropped: | Withdrawn (not marketed) |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/132062458 |
Guide to Pharmacology: | netilmicin |
Citations: |
|